Contraception Ad Claims That Get Rejected
Once the targeting and framing are right, claims are where contraception ads fail. These are the claim types that get pulled in platform review, flagged in legal review, or create exposure a brand does not need, and what to write instead.
Concepts shown are internal creative studies, not client campaigns.
A contraception ad can be targeted correctly, framed around health care, and still get rejected for a single line of voiceover. In this category the claim is often the part that fails, and it is also the part that carries risk beyond the platform. A rejected ad costs a day. A claim that reaches a regulator costs a great deal more.
The claim rules below are the ones we build every script around in our birth control ad creative, because a claim fixed at the brief stage costs nothing and a claim fixed after the edit costs a reshoot. The same patterns show up across pill, patch and ring brands, so they are worth learning once and writing into the brief template.
Why Claims Carry the Risk
Platform policy decides whether an ad runs. Advertising law decides whether it should have. In the United States the Federal Trade Commission sets the bar for health claims, and its Health Products Compliance Guidance, published on December 20, 2022, says health claims need competent and reliable scientific evidence, defined as tests, analyses, research or studies conducted and evaluated objectively by qualified experts and generally accepted in the profession to yield accurate and reliable results.
That standard applies to what the ad says and to what it implies. A viewer does not need to hear the word effective to come away believing a product works a certain way. The overall impression counts, which means a headline, a caption card and a testimonial can each create a claim on their own. Our guide on how to substantiate health claims in telehealth ads covers how to build the evidence file behind a claim you do intend to make.
Platform review may be moving the same way. Coverage of the July 2026 revision to Meta's Health and Wellness standards describes a shift toward judging ads by the claims they make rather than by product category. Meta has not published detail on that change, but the direction matches what legal review already expects: the words in the ad are where the risk lives.
Effectiveness Figures
The first pattern is a number. A percentage in the headline, a rate in the voiceover, or a superlative such as the most effective option available. Each of these is a health claim about a contraceptive, and each one has to be substantiated in the exact form and context in which it appears.
Figures lifted from somewhere else rarely meet that bar once they are cut down to fit a caption. The source may define the figure in a way the ad does not explain, or apply it to a population the ad does not reach. A number that is accurate in its original setting can be misleading in a six-second hook.
The rewrite moves the ad away from how well a method works and toward what the service does. A licensed clinician reviews your health history. The prescription is chosen with you, not for you. Refills arrive on schedule. None of those lines is a claim about the product, and all of them answer what a buyer is actually weighing when she chooses where to get a prescription.
Pregnancy Prevention Promises
The second pattern is the absolute promise. Never worry again. Total peace of mind. Protection you can count on. These lines rarely contain a number, which is why teams miss them, but the impression they create is a guarantee about outcome, and no advertiser can substantiate a guarantee.
They also sit awkwardly with Meta's focus test. Copy about not worrying often drifts toward the moment rather than the prescription, which invites a pleasure-focus reading on top of the claim problem.
The rewrite is continuity rather than certainty. Your prescription, refilled before you run out. A clinician you can message when something changes. That language describes the service the brand controls, not an outcome it cannot promise.
Comparisons to Other Methods
Comparative claims carry a double burden. Better than the pill. Easier than an IUD. The option doctors actually prefer. To make any of them, the brand needs support for its own side of the comparison and for the other side too, and that support rarely survives being compressed into an ad.
Comparisons that disparage a method the viewer may be using, or considering, create a second problem. The person who tracks her cycle, uses condoms, or is weighing an alternative is part of the audience. Telling her she is wrong is poor persuasion as well as a claim risk.
If an ad names a specific prescription product, the FDA's prescription drug advertising regulations at 21 CFR 202.1 become part of the review your regulatory counsel will run. The safest creative frame is to talk about choice and fit, not about ranking methods: several options exist, and the consultation is where the right one for her gets chosen.
Side Effect and Safety Language
The mirror image of an effectiveness claim is a safety claim. No side effects. Gentle on your body. Safe for everyone. Hormone free, so nothing to worry about. Each of these is a statement about how a product affects the body, and each needs the same substantiation as any other health claim.
The pressure to write these lines is understandable. Side effects dominate the public conversation about birth control, and brands want to answer that concern directly. The compliant answer is to address the concern through the service rather than the product. If something does not feel right, a clinician reviews it with you and the prescription can change. That acknowledges the experience without claiming anything about what a given method will or will not do.
This is what compliant telehealth creative looks like.
See the work →Testimonials and Disclosure
A testimonial does not create a safe harbor for a claim. The FTC's Health Products Compliance Guidance states the principle plainly: advertisers should not make claims through consumer testimonials or expert endorsements that would be deceptive or could not be substantiated if the advertiser made them directly. A creator who says she has had no side effects at all is making a safety claim on the brand's behalf.
Disclosure is the second requirement. Under the FTC's Endorsement Guides, a material connection between the brand and the person speaking, such as payment, free product or a commission, has to be disclosed clearly. Our guide to FTC endorsement rules for paid telehealth creators covers what that disclosure needs to look like on video.
Reviews carry their own rules. The FTC's rule on the use of consumer reviews and testimonials, which took effect on October 21, 2024, targets fake reviews and review manipulation, and selectively removing negative reviews creates a separate problem covered in why suppressing bad reviews is an FTC violation. For a birth control brand, where side effect complaints are a normal part of the review mix, that last point matters more than in most categories.
From Pricing Presented as a Total
The last pattern is not a health claim at all, but it causes friction in review and real exposure outside it. An ad shows a from price for the medication, and the consultation fee, the membership and the shipping appear only at checkout. The viewer reasonably reads the from price as what she will pay.
California has addressed this directly. According to the California Attorney General, the state's Honest Pricing Law, SB 478, took effect on July 1, 2024 and prohibits advertising or displaying a price for most consumer goods and services that does not include all mandatory fees or charges, excluding government taxes and reasonable shipping costs. A brand selling into California with a price that leaves out a mandatory consultation fee should have counsel review that ad.
The rewrite is simply the whole number. State the consultation fee and the recurring cost together, in the same place, before the viewer clicks. It reads as confidence, and in a category where trust is already thin it tends to be a better hook than a low number with an asterisk.
What Survives Review
The ads that clear review in this category describe the service rather than the drug. They show the consultation, the clinician who asks questions, the prescription that can change, the refill that arrives on time, and the full cost. Testimonials talk about the experience of getting care, not about what a method did to someone's body. Every paid voice is disclosed.
The Short Version
Contraception claims fail in six predictable ways: effectiveness figures, pregnancy prevention promises, comparisons to other methods, side effect and safety language, undisclosed or unsupported testimonials, and from prices shown as totals. Each has a rewrite that moves the ad from what the product does to what the service does. Write those rewrites into the brief, and the claim problems stop appearing at review.
Related Articles
Birth Control Advertising on Meta, What Gets Approved
How Meta reviews birth control ads. Adult targeting, the health versus pleasure focus test, certification rules, and what actually triggers a rejection.
Birth Control Ad Creative for Telehealth Brands
The creative angles that work for birth control telehealth brands: side effects taken seriously, refill friction, switching versus quitting, and total cost.
Hormone Hesitancy and What It Costs Telehealth Brands
Why birth control brands lose people to hormone hesitancy, why correcting them makes it worse, and the creative response that keeps the conversation open.
How to Substantiate Health Claims in Telehealth Ads
The FTC requires competent and reliable scientific evidence for health claims in telehealth ads. What that means in practice and how to build an evidence file.
Creative built to pass review, and convert anyway.
A 30-minute call. We audit your creative approach and show you exactly what a complete angle-format-hook system looks like for your vertical.








